MedPath

Care Plans for Cancer Predisposition

Not Applicable
Active, not recruiting
Conditions
Genetic Predisposition
Interventions
Other: Digital Care Plans
Registration Number
NCT05736497
Lead Sponsor
Children's Hospital of Philadelphia
Brief Summary

Develop and evaluate acceptability, feasibility, and preliminary efficacy of digital care plan and accompanying text message reminders for children and adolescents with a known Cancer Predisposition Syndromes (CPS).

Detailed Description

As over 15% of pediatric cancers are associated with a cancer predisposition, it is increasingly becoming standard of care for children with cancer, as well as those with suspected hereditary risk, to be evaluated for germline cancer predisposition. Unfortunately, the increase in pediatric genetic testing has exceeded the pace of research supporting effective cancer surveillance in positive cases. Additionally, guidelines for cancer predisposition management are not easily accessed or understood by families; thus, there is often a disconnect between the understanding and retention of such information relayed to families.

In this study, Investigators will develop and evaluate the acceptability, feasibility, and preliminary efficacy of digital care plans for Cancer Predisposition Syndromes (CPS) with accompanying text message reminders for children and adolescents with a known CPS. Digital care plans and text messages will be created for 10 common CPS. Investigators will use a quasi-experimental design with pre and post testing of the same cohort, before and after delivery of care plan and accompanying messages. To evaluate the impact of the digital care plans, Investigators will compare assessments of the same cohorts at 3 and 6 months time points.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
164
Inclusion Criteria

Parents

  1. Parent or Legal Guardian of a patient with a known cancer predisposition syndrome diagnosed within the last 5 years
  2. Received care at the Cancer Predisposition clinic at the Children's Hospital of Philadelphia (CHOP), or other medical institutions (does not need to be receiving follow-up care at CHOP)
  3. Appropriate to approach per oncology team/cancer predisposition team
  4. No cognitive impairment limiting ability to complete measures
  5. Ability to read and speak English fluently

Adolescent/Young Adult (AYA) probands

  1. Child proband with a known cancer predisposition syndrome diagnosed within the last 5 years
  2. Ages 12+
  3. Received care at the Cancer Predisposition clinic at the Children's Hospital of Philadelphia (CHOP), or other medical institutions (does not need to be receiving follow-up care at CHOP)
  4. Appropriate to approach per oncology team/cancer predisposition team
  5. No cognitive impairment limiting ability to complete measures
  6. Ability to read and speak English fluently
Read More
Exclusion Criteria
  • Not meeting any of inclusion criteria
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Intervention: Digital Care Plans with Accompanying Text MessagesDigital Care PlansInvestigators will recruit families and patients diagnosed with a Cancer Predisposition Syndrome within 3 years. Participants will be provided with a digital care plan and optional accompanying text message reminders.
Primary Outcome Measures
NameTimeMethod
Change in Knowledge Score of participating family members3 months and 6 months after receipt of digital care plan

Change in knowledge score for participating family members will be measured by participants completion of electronic questionnaires administered via REDCap. The change in the mean and standard deviation will be assessed at 3 months and 6 months. A higher score indicates greater knowledge of care plans content.

Secondary Outcome Measures
NameTimeMethod
Acceptability of use of digital care plans for CPS for participating family members3 months after receipt of digital care plan

Acceptability will be measured by participants completion of electronic questionnaires administered via REDCap. Acceptability ratings will be documented with standard descriptive statistics such as means and frequencies. A higher score indicates indicates higher satisfaction, perceived appropriateness, positive effect, demand, and potential for future use.

Feasibility of use of digital care plans for CPS for patients diagnosed within 5 yearsUp to 6 months after receipt of digital care plan

Feasibility will be assessed with absence of technical difficulties allowing the Clinical Research Coordinator (CRC) to create care plan in under 15 minutes in a busy clinical setting.

Satisfaction with decision to have germline testingUp to 6 months after receipt of digital care plan

Satisfaction with decision to have germline testing will be measured by participants completion of electronic questionnaires administered via REDCap. The change in the mean and standard deviation will be assessed at 3 months and 6 months and compared to baseline. A higher score indicates greater satisfaction with decision to have child genetically tested.

Change in cancer-related anxietyUp to 6 months after receipt of digital care plan

Cancer-related anxiety will be measured by participants completion of electronic questionnaires administered via REDCap. The change in the mean and standard deviation will be assessed at 3 months and 6 months and compared to baseline. A higher score indicates greater cancer-related stress.

Change in distress after receiving genetic test resultsUp to 6 months after receipt of digital care plan

Distress after receipt of genetic test results will be measured by participants completion of electronic questionnaires administered via REDCap. The change in the mean and standard deviation will be assessed at 3 months and 6 months and compared to baseline. A higher score indicates greater distress about genetic test result disclosure.

Trial Locations

Locations (1)

Children's Hospital of Philadelphia

🇺🇸

Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath